MEC Basic – MyMedflix Member Portal

Bladder Cancer Updates

Bladder Cancer Updates

David Benjamin, MD

Renal Cancer Updates

Renal Cancer Updates

Nataliya Mar, MD

Pancreatic and Hepatobiliary Updates

Pancreatic and Hepatobiliary Updates

Richard Finn, MD

Colon and Esophageal Cancer Updates

Colon and Esophageal Cancer Updates

Jun Gong, MD

CNS METS- Evolving Multidisciplinary Tumor Board Conversations Radiation Oncology

CNS METS- Evolving Multidisciplinary Tumor Board Conversations Radiation Oncology

Linda Chen, MD

CNS METS- Evolving Multidisciplinary Tumor Board Conversations Medical Oncology

CNS METS- Evolving Multidisciplinary Tumor Board Conversations Medical Oncology

Andrew Seidman, MD

Immunotherapy: Wait, Why Wait

Immunotherapy: Wait, Why Wait

VK Gadi, MD, PhD

Keynote Lecture: Genetics and RACE

Keynote Lecture: Genetics and RACE

Mark Robson, MD

The Art of Medicine in the Clinic

The Art of Medicine in the Clinic

Chelsea Gawryletz, MD

Metastatic HER2neu Positive Breast Cancer

Metastatic HER2neu Positive Breast Cancer

Chau Dang, MD

Post-Op Decision Making

Post-Op Decision Making

Anne O’Dea, MD

Neoadjuvant Candidacy and Treatment

Neoadjuvant Candidacy and Treatment

Anne O’Dea, MD

Stage 1A – De-Escalation v Escalation

Stage 1A – De-Escalation v Escalation

Chau Dang, MD

HER2 LOW Advanced and Metastatic Breast Cancer | How Low Do You Go?

HER2 LOW Advanced and Metastatic Breast Cancer | How Low Do You Go?

Komel Jhaveri, MD

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

VK Gadi, MD, PhD

Metastatic Interrogations and Recommendations

Metastatic Interrogations and Recommendations

VK Gadi, MD, PhD

Neoadjuvant Updates

Neoadjuvant Updates

Tiﬀany Traina, MD

Stage 1A TNBC: Treatment and Outcomes

Stage 1A TNBC: Treatment and Outcomes

Paolo Tarantino, MD

Cell Cycle and Immune Check Point Inhibitors | Research, Clinic, Patient

Cell Cycle and Immune Check Point Inhibitors | Research, Clinic, Patient

Hope Rugo, MD

Breast Cancer Recurrence Risk & Lifestyle Modifications

Breast Cancer Recurrence Risk & Lifestyle Modifications

Neil Iyengar, MD

Maturity of the Patient and evolving treatment options

Maturity of the Patient and evolving treatment options

Hyman Muss, MD

HR Positive Metastatic Breast Cancer - Are there Forks in the Road?

HR Positive Metastatic Breast Cancer - Are there Forks in the Road?

Neil Iyengar, MD

Neoadjuvant and Adjuvant Approaches

Neoadjuvant and Adjuvant Approaches

Claudine Isaacs, MD

ILC, When Non-scary Becomes Scary

ILC, When Non-scary Becomes Scary

Jason Aboudi Mouabbi, MD

Antibody Drug Conjugates Expanding a Targeted Assault on all Breast Cancer Subtypes

Antibody Drug Conjugates Expanding a Targeted Assault on all Breast Cancer Subtypes

Komel Jhaveri, MD

Breast Cancer Screening – Updates in Research and liquid Biopsy

Breast Cancer Screening – Updates in Research and liquid Biopsy

Kristina Rinker, PhD

Breast Cancer Screening – Updates in Breast Imaging

Breast Cancer Screening – Updates in Breast Imaging

Maxine Jochelson, MD, FSBI, FACR

Escalation

Quincy LaPlant, MD, PhD

De-Escalation

Beryl McCormick, MD

LCIS and ILC – Old Story with New Concerns

LCIS and ILC – Old Story with New Concerns

Timothy D’Alfonso, MD